Zobrazeno 1 - 10 of 82 pro vyhledávání: '"Seiji, Umemoto"'
1
Akademický článek
Preoperative nivolumab to evaluate pathological response in patients with stage I non-small cell lung cancer: a study protocol of phase II trial (POTENTIAL)
Autor: Kenichi Yoshimura, Atsushi Kagimoto, Yasuhiro Tsutani, Takahiro Mimae, Yoshihiro Miyata, Norihiko Ikeda, Hiroyuki Ito, Yoshimasa Maniwa, Kenji Suzuki, Masahiro Tsuboi, Seiji Umemoto, Morihito Okada
Publikováno v: BMJ Open, Vol 11, Iss 3 (2021)
Introduction Recently, inhibition of programmed cell death 1 or its ligand has shown therapeutic effects on non-small cell lung cancer (NSCLC). However, the effectiveness of preoperative nivolumab monotherapy for stage I NSCLC remains unknown. The pr
Externí odkaz: https://doaj.org/article/f0c5001a316041f5aa0ba7b54a8b11a9
Zobrazit plný text záznamu
2
Non-Fasting Hypertriglyceridemia as an Independent Risk Factor for Coronary In-Stent Restenosis after Primary Bare Metal Stent Implantation in Patients with Coronary Artery Disease
Autor: Reo Kawano, Toshiro Miura, Tatsuhiro Fujimura, Masakazu Tanaka, Michio Yamada, Tomoko Nao, Masayuki Yoshimura, Masafumi Yano, Seiji Umemoto, Mitsuyuki Hiromoto
Publikováno v: International Heart Journal. 62:970-979
After a percutaneous coronary intervention (PCI) in patients with coronary artery disease (CAD), in-stent neoatherosclerosis may pose a risk of in-stent restenosis (ISR). To clarify whether non-fasting hypertriglyceridemia contributes to ISR, we exam
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6075be8997626a50b6e6f4edc17da819
https://doi.org/10.1536/ihj.21-015
Zobrazit plný text záznamu
4
Dietary Adherence, Self-Efficacy, and Health Behavior Change of WASHOKU-Modified DASH Diet: A Sub-analysis of the DASH-JUMP Study
Autor: Junko Inagaki, Makoto Mitarai, Hiroko Kishi, Katsuko Kajiya, Seiji Umemoto, Hiroshi Oda, Sei Kobayashi, Atsuko Kawamura
Publikováno v: Current Hypertension Reviews
Background: We previously reported the nutritional characteristics and effects of the DASH-JUMP diet, which is a WASHOKU-modified DASH diet, in Japanese participants with untreated high-normal blood pressure or stage 1 hypertension. The dietary adher
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dae88547f55f326f39eafe1e33b0332
http://europepmc.org/articles/PMC7499351
Zobrazit plný text záznamu
6
Non-Fasting Hypertriglyceridemia as an Independent Risk Factor for Coronary In-Stent Restenosis after Primary Bare Metal Stent Implantation in Patients with Coronary Artery Disease
Autor: Masayuki, Yoshimura, Seiji, Umemoto, Reo, Kawano, Mitsuyuki, Hiromoto, Michio, Yamada, Tatsuhiro, Fujimura, Masakazu, Tanaka, Tomoko, Nao, Toshiro, Miura, Masafumi, Yano
Publikováno v: International heart journal. 62(5)
After a percutaneous coronary intervention (PCI) in patients with coronary artery disease (CAD), in-stent neoatherosclerosis may pose a risk of in-stent restenosis (ISR). To clarify whether non-fasting hypertriglyceridemia contributes to ISR, we exam
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::19047bfec21252dc491a6e57de48615a
https://pubmed.ncbi.nlm.nih.gov/34588411
Zobrazit plný text záznamu
7
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis
Autor: Milad Nazarzadeh, Morris J. Brown, Anthony Rodgers, Henry R. Black, Takao Saruta, Hiromichi Suzuki, Sverre E. Kjeldsen, Barry R. Davis, Anushka Patel, Edmund J. Lewis, John B. Kostis, Stevo Julius, Giuseppe Remuzzi, Jan A. Staessen, Stephan Lueders, Lutgarde Thijs, Ji-Guang Wang, Jan Lanke, Rory Collins, Amanda I Adler, Ray Estacio, Gianpaolo Reboldi, Yoshiki Yui, Yoshihiko Kanno, Michel Lievre, Ajay Gupta, Hiroshi Ogawa, Piero Ruggenenti, Maria H Mehlum, Peter Sleight, Craig S. Anderson, Tsuguya Fukui, Ale Algra, Jamie P. Dwyer, William C. Cushman, MA Pfeffer, Ettore Malacco, Julia B. Lewis, Kenji Ueshima, Peter S. Sever, Lars H Lindholm, Steven E. Nissen, Larry Agodoa, Dexter Canoy, Christopher J. Bulpitt, Robert P Byington, Zeinab Bidel, Richard J McManus, Giancarlo Viberti, N Beckett, Jasper J Brugts, Eivind Berge, Frank P. Brouwers, Jacobus Lubsen, Robert W. Schrier, Johan Sundström, Salim Yusuf, Lindon Wing, Zhen-Yu Zhang, Paul K. Whelton, Colin Baigent, Alberto Zanchetti, Toshio Ogihara, Barry M. Brenner, Jeffrey Cutler, Bruce Neal, Paolo Verdecchia, Dick de Zeeuw, Stephen MacMahon, Takayoshi Ohkubo, Emma Copland, Wiek H. van Gilst, Folkert W. Asselbergs, Neil R Poulter, Kristian Wachtell, Vlado Perkovic, Kazem Rahimi, Christopher M. Reid, Peter M. Rothwell, Seiji Umemoto, Hiromi Rakugi, Koon K. Teo, Kim Fox, Malgorzata Wamil, Masao Ishii, Mark Woodward, Fiona Turnbull, Kizuku Kuramoto, Richard B Devereaux, Christopher R. Palmer, Joachim Schrader, Carl J. Pepine, Robert Fagard, Giuseppe Mancia, Rury R. Holman, Masunori Matsuzaki, Eric Boersma, John Chalmers, Jeannette Majert, Gholamreza Salimi-Khorshidi, Bertram Pitt, Yutaka Imai
Publikováno v: The Lancet, 398(10305), 1053-1064. Elsevier Ltd.
Background The effects of pharmacological blood-pressure-lowering on cardiovascular outcomes in individuals aged 70 years and older, particularly when blood pressure is not substantially increased, is uncertain. We compared the effects of blood-press
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b32b7994875e1d4ad1d2b712dd71cf4f
https://doi.org/10.1016/s0140-6736(21)01921-8
Zobrazit plný text záznamu
8
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
Autor: Yoshiki Yui, Barry M. Brenner, Lutgarde Thijs, Stevo Julius, Seiji Umemoto, Peter M. Rothwell, Kristian Wachtell, Yutaka Imai, Giuseppe Remuzzi, Masao Ishii, Robert W. Schrier, Hiromi Rakugi, Ajay Gupta, Piero Ruggenenti, Mark Woodward, Ana-Catarina Pinho-Gomes, Paolo Verdecchia, Stephen MacMahon, Gholamreza Salimi-Khorshidi, Michel Lievre, Vlado Perkovic, Koon K. Teo, Neil R Poulter, Christopher M. Reid, Anthony Rodgers, Lindon Wing, Peter Sleight, Maria H Mehlum, Giancarlo Viberti, Ray Estacio, Jeffrey Cutler, Paul K. Whelton, Steven E. Nissen, Giuseppe Mancia, Bruce Neal, Milad Nazarzadeh, Ettore Malacco, Morris J. Brown, Kim Fox, Yoshihiko Kanno, Kenji Ueshima, Alberto Zanchetti, Toshio Ogihara, Craig S. Anderson, Anushka Patel, Masunori Matsuzaki, Jan Lanke, Fiona Turnbull, Gianpaolo Reboldi, Ale Algra, Kizuku Kuramoto, Richard B Devereaux, Larry Agodoa, Henry R. Black, John Chalmers, Colin Baigent, Christopher J. Bulpitt, Hiromichi Suzuki, Rory Collins, Robert Fagard, Edmund J. Lewis, Hiroshi Ogawa, Dick de Zeeuw, Tsuguya Fukui, Julia B Lewis, MA Pfeffer, Robert P Byington, John B. Kostis, Jan A. Staessen, Stephan Lueders, Amanda I Adler, Eivind Berge, William C. Cushman, Frank P. Brouwers, Lars H Lindholm, Dexter Canoy, Carl J. Pepine, Ji-Guang Wang, Emma Copland, Wiek H. van Gilst, Sverre E. Kjeldsen, Rema Ramakrishnan, Rury R. Holman, Peter S. Sever, Jamie P. Dwyer, Folkert W. Asselbergs, Zeinab Bidel, Takao Saruta, Nigel S Beckett, Christopher R. Palmer, Joachim Schrader, Bertram Pitt, Barry R. Davis, Johan Sundström, Salim Yusuf, Takayoshi Ohkubo, Jacobus Lubsen, Zhen-Yu Zhang, Kazem Rahimi
Publikováno v: The Lancet, 397(10285), 1625-1636. Elsevier Limited
Background The effects of pharmacological blood pressure lowering at normal or high-normal blood pressure ranges in people with or without pre-existing cardiovascular disease remains uncertain. We analysed individual participant data from randomised
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28b17f611df0472730f0c62968e45810
https://pure.amc.nl/en/publications/pharmacological-blood-pressure-lowering-for-primary-and-secondary-prevention-of-cardiovascular-disease-across-different-levels-of-blood-pressure-an-individual-participantlevel-data-metaanalysis(e47e1f76-6d3d-44ac-a7f7-ea9efe75f18f).html
Zobrazit plný text záznamu
9
Preoperative nivolumab to evaluate pathological response in patients with stage I non-small cell lung cancer: a study protocol of phase II trial (POTENTIAL)
Autor: Yoshimasa Maniwa, Atsushi Kagimoto, Kenji Suzuki, Masahiro Tsuboi, Yoshihiro Miyata, Yasuhiro Tsutani, Kenichi Yoshimura, Hiroyuki Ito, Takahiro Mimae, Morihito Okada, Norihiko Ikeda, Seiji Umemoto
Publikováno v: BMJ Open
BMJ Open, Vol 11, Iss 3 (2021)
IntroductionRecently, inhibition of programmed cell death 1 or its ligand has shown therapeutic effects on non-small cell lung cancer (NSCLC). However, the effectiveness of preoperative nivolumab monotherapy for stage I NSCLC remains unknown. The pre
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::480c7a8b2ab4f1bfee7d83833a618727
https://pubmed.ncbi.nlm.nih.gov/33737428
Zobrazit plný text záznamu
10
Effects of a Japanese Cuisine-Based Antihypertensive Diet and Fish Oil on Blood Pressure and Its Variability in Participants with Untreated Normal High Blood Pressure or Stage I Hypertension: A Feasibility Randomized Controlled Study
Autor: Sayaka Motoi, Seiji Umemoto, Uran Onaka, Reo Kawano, Makoto Mitarai, Atsuko Kawamura, Hiroki Kanazashi, Naoki Honda
Publikováno v: Journal of atherosclerosis and thrombosis. 29(2)
Aim The Dietary Approaches to Stop Hypertension (DASH) diet is recommended for lowering blood pressure (BP). Our previous single-arm trial revealed that the Japanese cuisine-based DASH (J-DASH) diet (supplying NaCl 8.0 g per day) reduced BP and impro
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13909677b64bf74109cb357e6b818ca7
https://pubmed.ncbi.nlm.nih.gov/33298663
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje